Global Obesity Management Market
Overview:
Obesity is the higher body mass index and extra body fat. Obesity is a common disease globally and it is witnessed in underdeveloped, emerging, and developing nations. Several surgeries like gastric sleeve, gastric bypass, intragastric balloon treatment and duodenal switch can be performed for treating obesity.
The global obesity management drugs market is forecast to account for US$ 764.7 Million in terms of value in 2020 and is estimated to reach US$ 1,078.9 Million by the end of 2027.
To Get More Business Strategies Request Sample Copy of This Research Report:) @ https://www.coherentmarketinsights.com/insight/request-sample/2824
Drivers:
Increasing research and developmental activities is anticipated to augment growth of the global obesity management market during the forecast period. For instance, a biopharmaceutical company VIVUS, Inc., in May 2019 declared the initiation of the phase IV for examining the efficacy and safety of Qsymia used for managing weight in obese patients.
Opportunities:
Increasing adoption of novel technologies for treating obesity is estimated to provide productive chances of growth for key players in the global obesity management market during the forecast period. For instance, researchers from Harvard University in August 2020, demonstrated the use of CRISPR-Cas9 gene-editing technology in to engineering human white fat for displaying the properties of brown fat.
Restraints:
Rising side effects and increasing safety concerns is estimated to hamper growth of the global obesity management market during the forecast period.
There has been a rapid increase in the obesity drug users owing to various benefits exhibited, whereas studies have shown that there are adverse health effects and few side effects such as diabetes, strokes, depression, high blood pressure, asthma, heart diseases, sleep apnea and cancer due to the prolonged use of obesity drugs.
For More Information or Query or Customization before Buying, Visit at – https://www.coherentmarketinsights.com/insight/talk-to-analyst/2824
Key Takeaways:
The global obesity management market is forecast to be valued at US$ 729.9 Million in 2019 and is estimated to reach a value of US$ 1,078.9 Million by 2027 over the forecast period. Rising incidences of obesity and increasing product launches is estimated to boost growth of the global obesity management drugs market over the forecast period.
Orlistat witnessed significant growth in the global obesity management drugs market, in 2019 which accounted for 31.9% share in terms of value, and it was followed by Liraglutide and Lorcaserin.
Market Trends:
Key players are focusing on adoption of partnerships and collaborations for the expansion of their product portfolio in the global obesity management market. For instance, NovoFit and Precor entered in a strategic partnership for distributing their product in Australia in June 2019. This partnership is aiming to increase their position in the Australian market.
The possibility of linking obesity with cancer is anticipated to fuel growth of the global obesity management market over the forecast period. For instance, according to a research conducted in the Washington University School of Medicine, U.S. in September 2020, stated that for every 5kg weight gain the chance of cancer rises by 5%.
Regulations
U.S
- A cheaper and faster new drug development pathway is offered under the 505(b)(2) regulation. The Drug Price Competition and Patent Term Restoration Act added the 505 (b)(2) to the FD&C act in1984.
- After a generic company files for ANDA with Paragraph IV certification, the first applicant to submit completed ANDA is provided with 180 days market exclusivity as per the para IV of Hatch-Waxman act.
- The U.S. Department of Health and Human Services Food and Drug Administration in October 1999, published the guidelines to be covered by applicants under section 505 (b)(2).
Key Players:
Key players active in the global obesity management market are Eisai Co., Ltd, F Hoffmann La Roche Ltd., Novo Nordisk A/S, GlaxoSmithKline plc., VIVUS, Inc., Orexigen Therapeutics, Inc. and Arena Pharmaceuticals, Inc.
Key Developments:
Key players are focusing on adoption of strategies like partnership and collaboration for the expansion of their portfolio in the global obesity management market. For instance, Eisai Co., Ltd. signed an agreement with CY Biotech for granting marketing and development rights of their lorcaserin hydrochloride an anti-obesity agent in China in July 2018.
Grab the Offer and Get UpTo 30% Discount on This Research Report 2022-2028 @ https://www.coherentmarketinsights.com/promo/buynow/2824
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Distribution Channel
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- Regulatory Scenario
- PEST Analysis
- COVID-19 Impact Analysis
- Market Dynamics
- Global Obesity Management Drugs Market, By Drug Type, 2019 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Bupropion and Naltrexone
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Orlistat
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Lorcaserin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Phentermine and Topiramate
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Liraglutide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Introduction
- Global Obesity Management Drugs Market, By Distribution Channel, 2019 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Hospitals Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- E-commerce
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
View Press Release: https://www.coherentmarketinsights.com/press-release/obesity-management-drugs-market-3476
About US:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837